Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Farmers Insurance
Deloitte
Citi
Cantor Fitzgerald
Federal Trade Commission

Generated: May 23, 2019

DrugPatentWatch Database Preview

Drug Sales Trends for ESCITALOPRAM

« Back to Dashboard

Payment Methods and Pharmacy Types for ESCITALOPRAM (2016)

Revenues by Pharmacy Type

Pharmacy Type Revenues
MAIL-ORDER $122,671,671
INSIDE ANOTHER STORE $193,736,265
[disabled in preview] $690,512,379
This preview shows a limited data set
Subscribe for full access, or try a Trial

Units Sold by Pharmacy Type

Pharmacy Type Units
MAIL-ORDER 1,879,280
INSIDE ANOTHER STORE 6,461,767
[disabled in preview] 15,072,197
This preview shows a limited data set
Subscribe for full access, or try a Trial

Revenues by Payment Method

Payment Method Revenues
MEDICAID $36,651,884
MEDICARE $348,385,228
[disabled in preview] $621,883,202
This preview shows a limited data set
Subscribe for full access, or try a Trial
Drug Sales Revenue Trends for ESCITALOPRAM
Drug Units Sold Trends for ESCITALOPRAM

Annual Sales Revenues and Units Sold for ESCITALOPRAM

These sales figures are drawn from a US national survey of drug expenditures
Drug Name Revenues (USD) Units Year
ESCITALOPRAM ➤ Try a Free Trial ➤ Try a Free Trial 2016
ESCITALOPRAM ➤ Try a Free Trial ➤ Try a Free Trial 2015
ESCITALOPRAM ➤ Try a Free Trial ➤ Try a Free Trial 2014
ESCITALOPRAM ➤ Try a Free Trial ➤ Try a Free Trial 2013
ESCITALOPRAM ➤ Try a Free Trial ➤ Try a Free Trial 2012
ESCITALOPRAM ➤ Try a Free Trial ➤ Try a Free Trial 2011
Drug Name Revenues (USD) Units Year

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
QuintilesIMS
US Department of Justice
Colorcon
Moodys
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.